South Dakota Investment Council Neurocrine Biosciences Inc Transaction History

South Dakota Investment Council

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$75.79 - $100.07 $246,090 - $324,927	-3,247 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$72.45 - $94.81 $1.22 Million - $1.6 Million	-16,853 Reduced 83.85%	3,247 $304,000
Q3 2021 Nov 09, 2021	BUY	$86.18 - $99.03 $1.73 Million - $1.99 Million	20,100 New	20,100 $1.93 Million

650

96.2M

380K

382K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $11B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of South Dakota Investment Council, based on Form 13F filings with the SEC.

Stay updated on South Dakota Investment Council with notifications on news.